Cholesterol lowering in the management of coronary artery disease: the clinical implications of recent trials

The American Journal of Medicine
D A Eisenberg

Abstract

Atherosclerotic vascular disease is the major cause of death and disability in adult men and women living in the United States, where 13-14 million adults have a history of coronary artery disease (CAD). One-third of the 1.5 million individuals who experience a myocardial infarction (MI) each year will die and one half of these deaths will occur within 60 minutes of the event. The relation between elevated serum lipids and CAD has been corroborated by epidemiologic as well as pathologic evidence. Approximately 96 million people have total cholesterol levels > 200 mg/dL, with 38 million of these individuals having values > 240 mg/ dL. The National Cholesterol Education Program (NCEP) identified elevated low-density lipoprotein (LDL) cholesterol as a primary risk factor for CAD in 1988. This conclusion, along with recommendations for assessment and treatment, was reaffirmed in 1993. The NCEP also recommended that high-risk patients, with or without clinical manifestations of coronary atherosclerosis, should substantially lower their serum cholesterol levels. Specifically, the NCEP recommends that patients with CAD need to maintain serum LDL cholesterol levels of < or = 100 mg/dL; this means that the vast majority of patients need...Continue Reading

Citations

Dec 18, 2013·Journal of Cheminformatics·Tobias GirschickStefan Kramer
Jul 17, 2008·Vascular Health and Risk Management·Y C ChanM G Irwin
Nov 4, 2010·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Liping ZhangXiaopeng Hu
Nov 3, 2005·Nature Clinical Practice. Cardiovascular Medicine·Gary Spektor, Valentin Fuster
Oct 3, 2003·Journal of Cellular Biochemistry·M Carmen García-PelayoMarina Martínez-Cayuela
Jun 14, 2001·The American Journal of Medicine·L M Bjerre, J LeLorier
Jun 17, 2008·The Journal of Infection·S BadiouUNKNOWN Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA)
May 1, 2008·Journal of Molecular Recognition : JMR·Valeriy V PakDae Young Kwon
May 18, 2004·The Surgical Clinics of North America·Jin-Woo Park, Orlo H Clark
Aug 13, 2002·Dermatologic Clinics·Jonelle K McDonnell
Jul 25, 2007·Clinical and Experimental Pharmacology & Physiology·Naoki TomiyamaKenji Matsuyama
Nov 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oriana YuLaurent Azoulay
Feb 13, 2007·Acta Cirúrgica Brasileira·José Luiz de Souza NetoAldo Cunha Medeiros
Dec 20, 2002·Journal of Cardiovascular Pharmacology and Therapeutics·V GaddamJ L Mehta
Mar 7, 2018·The Cochrane Database of Systematic Reviews·Stephen P AdamsJames M Wright
Nov 1, 2017·AIDS Patient Care and STDs·Jonathan V ToddAdaora A Adimora
May 9, 2007·Journal of Molecular Recognition : JMR·Valeriy V PakDae Young Kwon
Mar 28, 2008·The Korean Journal of Internal Medicine·UNKNOWN Atorvastatin Study Group in Korea
Jan 2, 2003·Nature Reviews. Cancer·James L Mulshine
Sep 28, 2014·The Oncologist·Kun-Tai HsuHerbert Chen
Mar 24, 2020·The Biochemical Journal·Nicole G BarraJonathan D Schertzer
Sep 26, 2013·Molecular and Cellular Biochemistry·Ramalingam AnandhiPitchairaj Geraldine
Apr 27, 2002·Heart Disease·N N Wong
Jul 22, 2018·Journal of Behavioral Medicine·Dan V BlalockCorrine I Voils
Aug 5, 2004·The Journal of Biological Chemistry·Nino CampobassoMichael N Gwynn
Dec 7, 2014·Disease Models & Mechanisms·Kieran McCaffertyMuhammad M Yaqoob
Dec 9, 2000·Biochimica Et Biophysica Acta·E S Istvan, J Deisenhofer
Jul 3, 2021·Cells·Rajakrishnan Veluthakal, Debbie C Thurmond

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.